Hanall Biopharma Co. Ltd. (009420)
Market Open
10 Aug, 06:30
KRX SM KRX SM Primary ₩
56,900. 00
+2,800
+5.1756%
₩
2.8T Market Cap
- P/E Ratio
- Div Yield
396,140 Volume
- Eps
₩ 54,100
Previous Close Want to track 009420 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Hanall Biopharma Co. Ltd. (009420) Statistics
Valuation metrics
Market Cap 2.8T
Enterprise value 2.76T
Trailing P/E (ttm) -112.22
Forward P/E -
PEG ratio -0.17
Price/Sales (ttm) 16.92
Price/Book (mrq) 17.41
Enterprise Value/Revenue 16.96
Enterprise Value/EBITDA -195.38
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 320.46K
Average volume (90 days) 521.42K
Price summary
52-Week low 27,050
52-Week high 73,000
Beta -
50-Day moving average 53,135.71
200-Day moving average 52,734.44
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 10:1
Last split Date 3 May 2006
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.15%
Operating margin 0.03%
Operational effectiveness
Return on assets -0.1%
Return on equity -0.16%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 3,113.64
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -476.7
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 692.14
Total debt (mrq) -
Total Debt/Equity (mrq) 0.27
Current ratio (mrq) 1.6%
Book value per share (mrq) 3,107.85
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
